Trial intelligence / Profile preview

Shexiang Tongxin Dropping Pills for Stable Angina (China Phase IV)

CTR20150062Phase 4Active

Sponsor
Inner Mongolia Yitai Pharmaceutical
Start
Feb 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Shexiang Tongxin Dropping Pills in coronary arteriosclerosis, angina pectoris, sponsored by Inner Mongolia Yitai Pharmaceutical. Started Feb 2015; status: active.

02

Drugs

Shexiang Tongxin Dropping Pills
03

Conditions

coronary arteriosclerosisangina pectoris

Beyond the preview

Go deeper on CTR20150062.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150062.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call